The Adherence and LDL-C Lowering Effect of Inclisiran Among Patients Who Received Treatment at Outpatient Clinics

被引：0
|
作者：
Desai, Nihar R.
Van Hise, Nicholas
Niu, Charlene
Ghera, Elizabeth
McElligott, Sean
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Atherosclerosis; Dyslipidemia; LDL; Cholesterol-lowering drugs; Cardiovascular disease;
D O I：
10.1161/circ.148.suppl_1.16180
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16180
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Effect of ezetimibe plus sinivastatin (EZE/SIMVA) on attainment of LDL-C treatment targets in hypercholesterolemic patients
    Ose, L.
    Shah, A. K.
    Davies, M. J.
    Mitchel, Y. B.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 202 - 203
  • [42] TO CORRECT OR NOT TO CORRECT (FOR TREATMENT): ESTIMATING PRETREATMENT LDL-C CONCENTRATIONS IN GENETICALLY CHARACTERIZED PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA ON LIPID-LOWERING MEDICATION
    Stevens, Christophe
    Elshorbagy, Amany
    Vallejo-Vaz, Antonio
    Dharmayat, Kanika
    Lyons, Alexander
    Bourbon, Mafalda
    Chora, Joana
    Humphries, Steve
    Catapano, Alberico
    Hovingh, G.
    Mata, Pedro
    Santos, Raul
    Soran, Handrean
    Watts, Gerald
    Raal, Frederick J.
    Freiberger, Tomas
    Ray, Kausik
    ATHEROSCLEROSIS, 2024, 395
  • [43] TREATMENT PATTERNS AND LDL-C CONTROL IN VERY HIGH-RISK PATIENTS RECEIVING LIPID-LOWERING THERAPY IN THE UNITED KINGDOM
    Beaini, Y.
    Danese, M.
    Sidelnikov, E.
    Villa, G.
    Catterick, D.
    Iqbal, M.
    Gleeson, M.
    Lubeck, D.
    Patel, J.
    VALUE IN HEALTH, 2020, 23 : S499 - S500
  • [44] ADHERENCE TO STATIN TREATMENT AND ACHIEVING LOW DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) GOALS IN AN EMPLOYEE POPULATION
    Chen, C. Y.
    Burton, W. N.
    Schultz, A. B.
    Tunceli, K.
    Edington, D. W.
    VALUE IN HEALTH, 2009, 12 (03) : A143 - A144
  • [45] ATTAINMENT OF LDL-C TREATMENT TARGET IN FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS: A THEORETICAL MODEL EXPLORING EFFICACY OF CURRENT AND NOVEL LIPID LOWERING THERAPIES
    Hartgers, M. L.
    Besseling, J.
    Hovingh, G. K.
    ATHEROSCLEROSIS, 2016, 252 : E43 - E44
  • [46] LDL-c-linked SNPs are associated with LDL-c and myocardial infarction despite lipid-lowering therapy in patients with established vascular disease
    van de Woestijne, Anton P.
    van der Graaf, Yolanda
    de Bakker, Paul I. W.
    Asselbergs, Folkert W.
    de Borst, Gert Jan
    Algra, Ale
    Spiering, Wilko
    Visseren, Frank L. J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2014, 44 (02) : 184 - 191
  • [47] Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS
    Ray, Kausik K.
    Bach, Richard G.
    Cannon, Christopher P.
    Cairns, Richard
    Kirtane, Ajay J.
    Wiviott, Stephen D.
    McCabe, Carolyn H.
    Braunwald, Eugene
    Gibson, C. Michael
    EUROPEAN HEART JOURNAL, 2006, 27 (19) : 2310 - 2316
  • [48] A TARGETED REVIEW OF PUBLISHED META-ANALYSES FOR LDL-C LOWERING TREATMENTS BEYOND STATINS: BEMPEDOIC ACID, EZETIMIBE, AND PCSK9-INHIBITORS INCLUDING INCLISIRAN
    Van Schoonhoven, A.
    Spentzouris, G.
    Westerink, L.
    Tiemens, A.
    Bilitou, A.
    Postma, M.
    VALUE IN HEALTH, 2022, 25 (01) : S24 - S25
  • [49] Hepatitis C treatment uptake among patients who have received methadone substitution treatment in the Republic of Georgia
    Stvilia, Ketevan
    Vephkvadze, Nino
    Gamkrelidze, Amiran
    Khonelidze, Irma
    Getia, Vladimer
    Tsereteli, Maia
    Gvinjilia, Lia
    Kuchuloria, Tainatin
    PUBLIC HEALTH, 2021, 195 : 42 - 50
  • [50] LDL-C Reduction With Lipid-Lowering Therapy for Primary Prevention of Major Vascular Events Among Older Individuals
    Andersson, Niklas Worm
    Corn, Giulia
    Dohlmann, Tine Lovso
    Melbye, Mads
    Wohlfahrt, Jan
    Lund, Marie
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (14) : 1381 - 1391
12345